Call Us at Support
+91 9654860915
A Named Patient Program (NPP), also referred to as a Managed Access Program, enables access to medicines for individual patients when a treating physician determines that a specific treatment is medically appropriate and not readily accessible through conventional local channels.
The program is intended to support patients with unmet medical needs by facilitating access to medicines on a patient-specific basis while adhering to applicable regulatory and ethical requirements.
Timely access to treatment can play an important role in patient care. Named Patient Programs help bridge access gaps by facilitating the supply of medicines that may not yet be available through standard commercial pathways.
A structured process that supports treatment access through medical evaluation, documentation review, regulatory coordination, and medicine supply.
Physician assesses the patient's condition and treatment requirements.
Prescriptions and supporting medical records are collected and reviewed.
Documentation is processed in line with applicable access and regulatory requirements.
Medicines sourced through authorized channels with ongoing patient support.
Facilitating medicine access requires coordination across sourcing, regulatory, quality, and logistics functions. Through an international network of manufacturers, pharmaceutical partners, and logistics providers, we support access for patients with unmet medical needs. Our team collaborates with healthcare professionals and global stakeholders to manage patient-specific access while ensuring compliance and patient-centered care.
Access to targeted therapies, immunotherapies, and other innovative cancer treatments.
Support for blood disorders, including leukemia, anemia, and rare hematological conditions.
Access to therapies for neurological and neurodegenerative disorders.
Innovative treatments for autoimmune and inflammatory diseases.
Specialized therapies for kidney diseases and renal complications.
Access to treatments for digestive, liver, and inflammatory bowel disorders.
Global therapies for cardiovascular diseases and heart-related conditions.
Access to orphan drugs and treatments for rare genetic and metabolic disorders.
Support for complex and highly specialized treatment requirements across multiple therapeutic fields.
The Named Patient Program is designed with a strong focus on patient safety, regulatory compliance, and ethical responsibility. Every request is managed on a patient-specific basis, ensuring proper documentation, quality assurance, and traceability while maintaining high standards of care throughout the medicine access process for safe treatment outcomes.
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9810469557We get back to you shortly during our working hours.